Aravive, Inc. (ARAV) Financial Statements (2024 and earlier)

Company Profile

Business Address RIVER OAKS TOWER
HOUSTON, TX 77098
State of Incorp. TX
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,35935,92453,68927,89646,83365,825
Cash and cash equivalents18,35935,92453,68927,89646,83365,825
Receivables    6,000  
Other undisclosed current assets3,6863,1394,2813,9434,4583,227
Total current assets:22,04539,06357,97037,83951,29169,052
Noncurrent Assets
Operating lease, right-of-use asset1,0921,2771,4621,6481,8342,020
Property, plant and equipment204240270295330365
Restricted cash and investments2,3922,4582,4452,4362,4312,431
Other noncurrent assets466453
Total noncurrent assets:3,6923,9814,1834,3834,6004,819
TOTAL ASSETS:25,73743,04462,15342,22255,89173,871
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,44614,44015,50317,77716,50913,086
Employee-related liabilities1,6991,307
Accounts payable3,8939,7948,7658,8214,7004,246
Accrued liabilities5,5534,6466,7387,25710,5028,840
Deferred revenue 2,6303,5824,4145,4324,0234,423
Other undisclosed current liabilities2,1452,1702,1955219382,271
Total current liabilities:14,22120,19222,11223,73021,47019,780
Noncurrent Liabilities
Long-term debt and lease obligation:    2,4262,9663,516
Liabilities, other than long-term debt31,33361,46329,3841,0241,3892,604
Deferred revenue 16286211,0241,3892,604
Operating lease, liability8211,3471,8822,4262,9663,516
Derivative instruments and hedges, liabilities30,49660,08826,881   
Other undisclosed noncurrent liabilities      8,772
Total noncurrent liabilities:31,33361,46329,3843,4504,35514,892
Total liabilities:45,55481,65551,49627,18025,82534,672
Equity
Equity, attributable to parent(19,817)(38,611)10,65715,04230,06639,199
Common stock666332
Additional paid in capital628,252627,466626,778602,041601,402592,059
Accumulated deficit(648,075)(666,083)(616,127)(587,002)(571,339)(552,862)
Total equity:(19,817)(38,611)10,65715,04230,06639,199
TOTAL LIABILITIES AND EQUITY:25,73743,04462,15342,22255,89173,871

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues1,2741,4911,4744,9561,6151,092
Sublease income700700800700700700
Gross profit:1,2741,4911,4744,9561,6151,092
Operating expenses(13,860)(19,404)(21,338)(21,504)(21,042)(16,090)
Operating loss:(12,586)(17,913)(19,864)(16,548)(19,427)(14,998)
Nonoperating income (expense)30,594(32,043)(9,261)8859501,941
Investment income, nonoperating3524674331476310
Other nonoperating income650697697738705703
Income (loss) from continuing operations:18,008(49,956)(29,125)(15,663)(18,477)(13,057)
Loss before gain (loss) on sale of properties:(15,663)(18,477)(13,057)
Net income (loss) attributable to parent:18,008(49,956)(29,125)(15,663)(18,477)(13,057)
Preferred stock dividends and other adjustments (29,592)     
Other undisclosed net income available to common stockholders, basic 29,592     
Net income (loss) available to common stockholders, basic:18,008(49,956)(29,125)(15,663)(18,477)(13,057)
Other undisclosed net loss available to common stockholders, diluted (29,592)     
Net income (loss) available to common stockholders, diluted:(11,584)(49,956)(29,125)(15,663)(18,477)(13,057)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):18,008(49,956)(29,125)(15,663)(18,477)(13,057)
Comprehensive income (loss), net of tax, attributable to parent:18,008(49,956)(29,125)(15,663)(18,477)(13,057)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: